18 May 2013
Keywords: enrollment, ph, iii, je, vacc, trials, complete
Article | 24 April 2006
Cambridge, UK-headquartered vaccine specialist Acambis says that it has completed patient enrollment into two pivotal Phase III clinical studies
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
12 June 2006
17 May 2013
© 2013 thepharmaletter.com